Figure 2. Change In Serum Phosphorus (mg/dl) From Baseline To Week 2 By Subgroup (Sevelamer Fig1)
Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 16714-814
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 16714-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 3. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Sevelamer Fig2)
The text describes a figure showing the percentage of patients who achieved a reduction in serum phosphorus levels (mg/dL) compared to baseline. The Y-axis represents the percentage of patients, while the X-axis shows the reduction in serum phosphorus levels. The figure includes data for both an active group and a control group.*
Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Fig3)
This figure shows the mean change in phosphorus levels among patients who completed 52 weeks of treatment with Sevelamer Hydrochloride compared to an active control. The graph indicates the phosphorus change from the baseline at different study weeks, with week 0 being the baseline.*
Package Label-principal Display Panel (800 mg (270 Tablets Bottle))
Each film-coated tablet contains 800mg of sevelamer carbonate as an active ingredient, manufactured by Northstar Rx LLC in Memphis, TN. The inactive ingredients are acetylated monoglycerides, ammonium hydroxide, black iron oxide, colloidal silicon dioxide, crospovidone, giyceryl dibehenate, hydroxypropyl cellulose, hypromellose, and talc. The usual dosage is as per the package insert, and the tablets should be stored at 20°C to 26°C (68°F to 77°F) in a tightly closed container protected from moisture. The tablet's total quantity is 270, and the manufacturing date is not specified.*
Chemical Structure (Sevelamer Str)
This is a chemical structure of Sevelamer Carbonate where it is composed of 9 primary amine groups and 1 crosslinking group which forms an extended polymer network. No other information is available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
